ME

23andMe (ME)

23andMe Holding Company

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:ME

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/09/25	20:30	GlobeNewswire Inc.	23andMe Launches New Genetic Report on Likelihood of Frequent Emotional Eating	NASDAQ:ME	23andMe Holding Company
2024/09/19	05:39	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ME	23andMe Holding Company
2024/09/18	21:10	Edgar (US Regulatory)	Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]	NASDAQ:ME	23andMe Holding Company
2024/09/18	21:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ME	23andMe Holding Company
2024/09/18	19:13	IH Market News	Meta Strengthens Child Privacy on Instagram; Google Overturns $1.7 Billion Antitrust Fine; Snap Updates Spectacles	NASDAQ:ME	23andMe Holding Company
2024/09/18	05:26	GlobeNewswire Inc.	Independent Directors of 23andMe Resign from Board	NASDAQ:ME	23andMe Holding Company
2024/09/15	16:00	GlobeNewswire Inc.	23andMe Therapeutics Announces Phase 2 Results for Two Additional Cancer Cohorts and Correlative Biomarker Data from 23ME-00610 Study	NASDAQ:ME	23andMe Holding Company
2024/09/15	16:00	GlobeNewswire Inc.	23andMe Therapeutics Announces Positive In Vivo Results for 23ME-01473, a Dual-Mechanism ULBP6-Targeting Antibody Currently in a Phase 1 Trial	NASDAQ:ME	23andMe Holding Company
2024/09/13	05:05	GlobeNewswire Inc.	One of the Largest and Most Diverse Studies on Sickle Cell Trait and Blood Clots Reveals Findings That Impact All Populations	NASDAQ:ME	23andMe Holding Company
2024/09/12	19:02	IH Market News	Norfolk Southern CEO Fired, Ryanair Lowers Fare Forecast, 23andMe Considers Acquisition Proposals	NASDAQ:ME	23andMe Holding Company
2024/09/12	05:45	Edgar (US Regulatory)	Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]	NASDAQ:ME	23andMe Holding Company
2024/09/03	20:30	GlobeNewswire Inc.	23andMe to Present Updates on Clinical Immuno-oncology Programs 23ME-00610 and 23ME-01473 at ESMO Congress 2024	NASDAQ:ME	23andMe Holding Company
2024/08/29	05:32	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ME	23andMe Holding Company
2024/08/29	05:31	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ME	23andMe Holding Company
2024/08/28	20:30	GlobeNewswire Inc.	Lemonaid Health Now Offering GLP-1 Medication Through Weight Loss Membership Program	NASDAQ:ME	23andMe Holding Company
2024/08/28	05:08	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ME	23andMe Holding Company
2024/08/22	06:41	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ME	23andMe Holding Company
2024/08/22	06:29	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ME	23andMe Holding Company
2024/08/09	05:11	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:ME	23andMe Holding Company
2024/08/09	05:06	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ME	23andMe Holding Company
2024/08/09	05:05	GlobeNewswire Inc.	23andMe Reports First Quarter Fiscal 2025 Financial Results	NASDAQ:ME	23andMe Holding Company
2024/08/05	18:43	IH Market News	Nvidia AI Chip Delays, Mars Eyes Kellanova Acquisition, Berkshire Hathaway’s Cash Surge to $277 Billion	NASDAQ:ME	23andMe Holding Company
2024/08/02	21:19	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ME	23andMe Holding Company
2024/08/02	21:00	GlobeNewswire Inc.	23andMe Special Committee responds to CEO’s take-private proposal	NASDAQ:ME	23andMe Holding Company
2024/08/01	21:09	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ME	23andMe Holding Company
2024/08/01	21:00	GlobeNewswire Inc.	23andMe Announces CEO’s Take-Private Proposal	NASDAQ:ME	23andMe Holding Company
2024/08/01	06:01	Edgar (US Regulatory)	Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]	NASDAQ:ME	23andMe Holding Company
2024/07/26	05:45	GlobeNewswire Inc.	23andMe to Report Q1 FY2025 Financial Results	NASDAQ:ME	23andMe Holding Company
2024/07/25	20:30	GlobeNewswire Inc.	Twenty Lung Cancer Advocacy Organizations and 23andMe Come Together to Launch Lung Cancer Genetics Study to Help Advance Research	NASDAQ:ME	23andMe Holding Company
2024/07/17	05:54	Edgar (US Regulatory)	Form ARS - Annual Report to Security Holders	NASDAQ:ME	23andMe Holding Company